ACTINIUM PHARMACEUTICALS, INC. (ATNM) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ATNM…

ACTINIUM PHARMACEUTICALS, INC. (ATNM) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

ACTINIUM PHARMACEUTICALS, INC.

ATNM · CIK 1388320

4 · Oct 16, 2026 · Chief Financial Officer David Matthew T was granted 500K shares

4

Chief Financial Officer David Matthew T was granted 500K shares

Filed: Oct 16, 2026
Period: Oct 14, 2026
Accession: 0001213900-26-110340
Filer: Actinium Pharmaceuticals, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov